Microsoft buys eugenics technology from Merck, becomes drug development partner with top global vaccine manufacturer

Posted: February 2, 2012 in HEALTH, NEWS, POLICE STATE
Tags: , , , , , , , , , , , , , ,

Thursday, February 02, 2012
by Mike Adams, the Health Ranger

(NaturalNews) When you buy Microsoft products, you are now promoting the pharmaceutical industry and its global vaccine agenda. That’s the new reality in which we live, where the world’s largest software company is “in bed” with the world’s largest vaccine pusher.

How so? In 2009, Microsoft purchased a key piece of technology from the drug company Merck, the world’s largest maker of vaccines (which Bill Gates says can help “reduce the global population” by 10 to 15 percent). That technology, as you’ll see below, can conceivably be used to develop eugenics vaccines that target specific races and nationalities with infertility-inducing pharmaceuticals — something that is entirely consistent with Bill Gates’ openly-admitted goal of reducing world population through the use of vaccines (see link to video below).

This gene-targeting vaccine research technology purchased by Microsoft was developed by the company known as Rosetta Biosciences, formerly owned by Merck. Their software is described as a way to “figure out how genes interact with each other, analyze peptides and metabolites, and determine how they relate to gene expression.” (…)


  1. Tylon says:

    Man, sometimes I feel lucky to be in prison. Sure, I gotta watch my back constantly and it can be real dangerous, but I think you people on the outside might finally have more to worry about than me! I would hope Mr. Gates wouldn’t wanna target me given that I just became a Microsoft certified IT professional, but who am I kiddin’? I think now than ever we all need to make sure we always give others the benefit of the doubt FIRST. No need for anybody to be fighting or angry.

  2. Reblogged this on bluepearlgirl's world and commented:
    this is not good!

  3. […] Microsoft buys eugenics technology from Merck, becomes drug development partner with top global vacc… ( […]

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s